vaccine confidence

Dear Research Advocate, As President Biden said yesterday during his inaugural address, “With unity, we can do great things. Important things.” Science has long been a unifier — for the public and policymakers alike — and, due to the pandemic, is more in the forefront now than in many, many years. Science is the right partner for “The hill we climb; If only we dare”, in the words of inaugural poet Amanda Gorman. Last week’s announcement of the elevation of the Office of Science and Technology Policy (OSTP) director to the President’s Cabinet was groundbreaking, placing science and technology at the table, in the most literal sense. The nomination of Dr. Eric Lander as Presidential Science...
The COVID-19 pandemic has had an unprecedented impact on the United States and the world, with extraordinary human tragedy and economic disruption. Since March 2, 2020, nearly 400,000 people in the United States have died of COVID-19 and more than 21 million cases have been identified. Over the next month, an estimated 820,000 to two million new cases are projected in the U.S. As COVID-19 cases continue to surge, the FDA’s authorization of the Pfizer and Moderna vaccines is a critical step towards immobilizing the spread of COVID-19. But ensuring a critical mass of people are vaccinated is essential in bringing an end to the pandemic. According to a recent JAMA article , the share of U.S...
Dear Research Advocate, Supplemental Funding Needs, Part 1 : President-elect Biden has indicated he will seek bipartisan support for a supplemental funding measure to address the urgent and ever-evolving needs created by this vicious and ongoing pandemic. Research!America has sent a letter to the President-elect with several supplemental funding requests, and we will follow up with a letter to Congressional leadership. Earlier this week we held an alliance member meeting with NIH Principal Deputy Director Dr. Larry Tabak and Deputy Director for Extramural Research Dr. Michael Lauer ( recording here ). Every minute of this meeting provided vital information on how the agency is struggling to...
With 2020 in our rearview mirror, we’re taking a look back at our 10 most popular blog posts (based on page views) for the year. The posts cover a wide range of topics including basic and clinical research, public health, clinical trials, and the impacts of COVID-19. We thank our distinguished group of guest bloggers including young researchers, academics, industry experts, public health professionals, and patient advocates as well as the staff here at Research!America who are united in support for stronger investments in research and innovation to combat diseases and build a safer, stronger, healthier nation. 1) Explained: How a COVID-19 Serology Test Works and Obstacles to its Use May 19...
Dear Research Advocate, Leadership Required : For so many of us, the events of the last 24 hours are difficult to fully comprehend. Our nation has experienced a profound shock to our democracy. The tragic overlay to this tumultuous time is that our nation faces an enemy that thrives on the very distrust, turmoil, and political gridlock we have been witnessing. COVID-19 has now killed more than 360,000 Americans — more lives lost in just ten months than the entire population of 99.7% of the cities and towns in this nation. In addition to assuring the peaceful transition of power to a new Administration, federal, state, and local lawmakers, and leaders from all sectors, can — and they must —...
Dear Research Advocate, Earlier this week, Congress passed a long-awaited legislative package containing FY21 funding and COVID-19 emergency dollars. However, President Trump has publicly criticized the bill and of this writing, it’s unclear whether he will sign it or seek changes. The current Continuing Resolution keeping the federal government open expires on December 28, 2020. Needless to say, we are closely monitoring the situation. Let’s look at the bill Congress approved: For FY21, it contains increases over the prior year of over $1 billion for NIH, $200 million for NSF, $125 million for the CDC, and $42 million for the FDA. Unfortunately, the Agency for Healthcare Research and...
Dear Research Advocate, Lame-Duck Session : Congressional lame-duck sessions can be busy, and the current one is no exception. The appropriations front remains quite fluid – while there were some signs that lawmakers would be able to move an FY21 omnibus funding package before the current Continuing Resolution (CR) expires on December 11, we are once again hearing that another short term CR may be necessary. Meanwhile, after weeks of inaction, there has been movement on the COVID-19 supplemental front. A group of bipartisan lawmakers this week released a $908 billion relief proposal as the basis for renewed negotiations. Will FY21 appropriations and the supplemental finally move forward?...
Dear Research Advocate, Phase 3 enrollment is now underway for a number of COVID-19 vaccine clinical trials. That science has moved so quickly from first identification of the virus to Phase 3 trials, speaks to remarkable public-private sector collaboration. It also speaks to the absolute necessity of taxpayer investment in basic, discovery science over many years; a lesson we must not ignore as we plan responses to the pandemics that will surely follow. To help move the massive trial enrollment process along, NIH has launched the COVID-19 Prevention Trials Network (COVPN), merging networks already funded by NIAID for HIV and other infectious disease trials. Each of the Phase 3 clinical...
When planning began for the 2020 Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases (NFID), the novel coronavirus (SARS-CoV-2) that causes COVID-19 had yet to emerge. Since then, the world has changed dramatically. There have been more than 1.8 million cases and more than 100,000 deaths due to COVID-19 in the U.S. alone since December 2019, with nearly 1,000 new deaths reported each day. COVID-19 has devastated economies across the globe, and here in the U.S., more than 36 million individuals have lost their jobs. Lives have been disrupted, and cultures have had to adapt. Meetings, weddings, and graduation ceremonies are now held virtually...

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor